[{"data":1,"prerenderedAt":155},["ShallowReactive",2],{"drug-olopatadine-eye":3},{"id":4,"schemaVersion":5,"name":6,"category":9,"class":10,"brands":13,"synonyms":19,"formulations":26,"regimens":39,"contraindications":66,"warnings":86,"renal":87,"monitoring":88,"interactions":89,"review":90,"examples":93,"atc":103,"iran":105,"links":125,"populations":140,"usApproval":150},"olopatadine-eye",1,{"fa":7,"en":8},"قطره چشمی اولوپاتادین","Olopatadine eye drops","sensory-organs",{"fa":11,"en":12},"آنتی‌هیستامین\u002Fپایدارکننده ماست‌سل چشمی","Ophthalmic antihistamine \u002F mast-cell stabiliser",[14,17],{"name":15,"market":16},"Pataday","US",{"name":18,"market":16},"Patanol",[20,21,22,23,24,25],"pataday","patanol","پاتانول","اولوپاتادین","آلرژی چشم","خارش چشم",[27],{"id":28,"form":29,"route":30,"label":31,"concentration":32,"markets":34,"refs":35},"sol-0-1","eye-drops","ophthalmic","0.1% eye drops",{"amount":5,"unit":33,"perUnit":33},"drop",[16],[36],{"source":37,"section":38},"fda-pataday-bid","Principal Display Panel",[40],{"id":41,"disease":42,"label":43,"population":46,"type":50,"unit":33,"dose":51,"refs":53,"limits":56,"notes":59},"allergic","allergic-conjunctivitis",{"fa":44,"en":45},"خارش چشم آلرژیک — ۲ سال به بالا: ۱ قطره دو بار در روز","Allergic itchy eyes — ≥2 y: 1 drop twice daily",{"minAge":47},{"value":48,"unit":49},2,"year","fixed",{"perDose":5,"dosesPerDay":48,"intervalHours":52},6,[54],{"source":37,"section":55},"Directions",{"maxPerDay":48,"refs":57},[58],{"source":37,"section":55},[60],{"text":61,"refs":64},{"fa":62,"en":63},"هر ۶ تا ۸ ساعت، حداکثر دو بار در روز. با قطره دیگر حداقل ۵ دقیقه فاصله. زیر ۲ سال: با پزشک مشورت شود.","Every 6–8 hours, no more than twice a day. Wait 5 minutes between eye products. Under 2 years: consult a doctor.",[65],{"source":37,"section":55},[67,77],{"id":68,"severity":69,"rule":70,"text":72,"refs":75},"under-2","block",{"maxAge":71},{"value":48,"unit":49},{"fa":73,"en":74},"زیر ۲ سال: با پزشک مشورت شود (دوز OTC ندارد).","Under 2 years: consult a doctor (no OTC dose).",[76],{"source":37,"section":55},{"id":78,"severity":79,"text":80,"refs":83},"lens","warn",{"fa":81,"en":82},"برای تحریک ناشی از لنز تماسی استفاده نشود؛ در صورت تغییر رنگ یا کدر شدن محلول مصرف نشود.","Not for contact-lens irritation; do not use if solution changes colour or becomes cloudy.",[84],{"source":37,"section":85},"Do not use",[],[],[],[],{"status":91,"reviewer":92,"date":92},"unverified",null,[94,98],{"regimen":41,"formulation":28,"input":95,"expect":97},{"ageYears":52,"weightKg":96},20,{"perDose":5,"perDay":48},{"regimen":41,"formulation":28,"input":99,"expect":101},{"ageYears":5,"weightKg":100},10,{"status":102},"blocked",[104],"S01GX09",{"status":106,"forms":107,"refs":120},"registered",[108,112,116],{"code":109,"en":110,"fa":111},"18871","OLOPATADINE 0.6% NASAL SPRAY","اسپری بینی اولوپاتادین ۰٫۶ درصد",{"code":113,"en":114,"fa":115},"12282","OLOPATADINE 5MG\u002F5ML OPH DROP","قطره چشمی اولوپاتادین ۵ میلی‌گرم \u002F ۵ میلی‌لیتر",{"code":117,"en":118,"fa":119},"52459","OLOPATADINE HYDROCHLORIDE SPRAY NASAL 0.6 % 15 mL","اسپری بینی اولوپاتادین هیدروکلراید ۰٫۶ درصد ۱۵ میلی‌لیتر",[121],{"source":122,"section":123,"url":124},"darooyab-generic","G-814\u002FOlopatadine","https:\u002F\u002Fwww.darooyab.ir\u002FG-814\u002FOlopatadine",[126,130,134,137],{"kind":127,"url":128,"label":129},"fda","https:\u002F\u002Fwww.accessdata.fda.gov\u002Fscripts\u002Fcder\u002Fdaf\u002Findex.cfm?event=overview.process&ApplNo=020688","NDA020688",{"kind":131,"url":132,"label":133},"dailymed","https:\u002F\u002Fdailymed.nlm.nih.gov\u002Fdailymed\u002FdrugInfo.cfm?setid=b7a24375-25df-4405-aa7c-34c46af51194","FDA Pataday (OTC)",{"kind":135,"url":136,"label":104},"who-atc","https:\u002F\u002Fatcddd.fhi.no\u002Fatc_ddd_index\u002F?code=S01GX09",{"kind":138,"url":124,"label":139},"darooyab","Olopatadine",{"pregnancy":141},{"level":142,"quote":143,"text":144,"refs":147},"caution","مصرف در بارداری اولوپاتادین گروه C در شرايط خاص و نظارت ويژه پزشك قابل استفاده است:",{"fa":145,"en":146},"دارویاب: گروه C — فقط اگر فایده بیشتر از خطر باشد.","Darooyab: category C — only if benefit outweighs risk.",[148],{"source":122,"section":149,"url":124},"G-814\u002FOlopatadine — مصرف در بارداری",{"kind":151,"refs":152,"id":129},"NDA",[153],{"source":37,"section":154},"SPL approval \u002F marketing category",1792191880652]